Extendicare Inc. (EXETF)
USD 7.0
(-0.71%)
USD 7.0
(-0.71%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 314.63 Million CAD | -13.74% |
| 2022 | 364.73 Million CAD | -21.27% |
| 2021 | 463.27 Million CAD | -6.07% |
| 2020 | 493.2 Million CAD | 16.73% |
| 2019 | 422.53 Million CAD | -7.0% |
| 2018 | 454.34 Million CAD | -4.63% |
| 2017 | 476.4 Million CAD | 6.16% |
| 2016 | 448.74 Million CAD | 4.68% |
| 2015 | 428.67 Million CAD | -5.41% |
| 2014 | 453.2 Million CAD | -55.43% |
| 2013 | 1.01 Billion CAD | -2.12% |
| 2012 | 1.03 Billion CAD | 10.3% |
| 2011 | 941.74 Million CAD | 44.19% |
| 2010 | 653.12 Million CAD | -45.82% |
| 2009 | 1.2 Billion CAD | -6.59% |
| 2008 | 1.29 Billion CAD | 30.19% |
| 2007 | 991.33 Million CAD | 18.33% |
| 2006 | 837.75 Million CAD | 8.06% |
| 2005 | 775.24 Million CAD | 26.33% |
| 2004 | 613.65 Million CAD | -18.19% |
| 2003 | 750.09 Million CAD | -11.41% |
| 2002 | 846.73 Million CAD | 7.41% |
| 2001 | 788.35 Million CAD | -1.75% |
| 2000 | 802.42 Million CAD | -10.04% |
| 1999 | 891.95 Million CAD | -11.18% |
| 1998 | 1 Billion CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 124.27 Million CAD | -54.33% |
| 2024 Q1 | 272.12 Million CAD | -13.51% |
| 2023 Q2 | 380.46 Million CAD | 0.78% |
| 2023 Q4 | 314.63 Million CAD | -1.28% |
| 2023 Q1 | 377.52 Million CAD | 3.51% |
| 2023 FY | 314.63 Million CAD | -13.74% |
| 2023 Q3 | 318.7 Million CAD | -16.23% |
| 2022 Q4 | 364.73 Million CAD | 4.34% |
| 2022 FY | 364.73 Million CAD | -21.27% |
| 2022 Q1 | 342.33 Million CAD | -26.11% |
| 2022 Q3 | 349.55 Million CAD | 0.05% |
| 2022 Q2 | 349.39 Million CAD | 2.06% |
| 2021 Q2 | 439.3 Million CAD | -6.23% |
| 2021 Q3 | 433.18 Million CAD | -1.39% |
| 2021 Q4 | 463.27 Million CAD | 6.95% |
| 2021 Q1 | 468.49 Million CAD | -5.01% |
| 2021 FY | 463.27 Million CAD | -6.07% |
| 2020 Q4 | 493.2 Million CAD | -1.27% |
| 2020 FY | 493.2 Million CAD | 16.73% |
| 2020 Q3 | 499.55 Million CAD | -1.73% |
| 2020 Q2 | 508.35 Million CAD | 16.0% |
| 2020 Q1 | 438.24 Million CAD | 3.72% |
| 2019 Q1 | 451.49 Million CAD | -0.63% |
| 2019 FY | 422.53 Million CAD | -7.0% |
| 2019 Q2 | 469.77 Million CAD | 4.05% |
| 2019 Q3 | 463.86 Million CAD | -1.26% |
| 2019 Q4 | 422.53 Million CAD | -8.91% |
| 2018 Q1 | 347.14 Million CAD | -27.13% |
| 2018 Q3 | 459.66 Million CAD | 0.73% |
| 2018 Q4 | 454.34 Million CAD | -1.16% |
| 2018 FY | 454.34 Million CAD | -4.63% |
| 2018 Q2 | 456.33 Million CAD | 31.45% |
| 2017 Q2 | 495.56 Million CAD | 6.45% |
| 2017 Q4 | 476.4 Million CAD | -0.98% |
| 2017 FY | 476.4 Million CAD | 6.16% |
| 2017 Q1 | 465.52 Million CAD | 3.74% |
| 2017 Q3 | 481.1 Million CAD | -2.92% |
| 2016 Q2 | 399.85 Million CAD | -1.0% |
| 2016 FY | 448.74 Million CAD | 4.68% |
| 2016 Q4 | 448.74 Million CAD | -0.81% |
| 2016 Q3 | 452.42 Million CAD | 13.15% |
| 2016 Q1 | 403.89 Million CAD | -5.78% |
| 2015 Q1 | 447.89 Million CAD | -1.17% |
| 2015 Q4 | 428.67 Million CAD | -2.41% |
| 2015 Q3 | 439.28 Million CAD | -1.04% |
| 2015 Q2 | 443.91 Million CAD | -0.89% |
| 2015 FY | 428.67 Million CAD | -5.41% |
| 2014 Q1 | 1.03 Billion CAD | 2.0% |
| 2014 FY | 453.2 Million CAD | -55.43% |
| 2014 Q3 | 1.16 Billion CAD | 5.07% |
| 2014 Q4 | 453.2 Million CAD | -61.18% |
| 2014 Q2 | 1.11 Billion CAD | 7.15% |
| 2013 Q1 | 1.04 Billion CAD | 0.65% |
| 2013 Q3 | 1 Billion CAD | 2.18% |
| 2013 Q4 | 1.01 Billion CAD | 0.75% |
| 2013 FY | 1.01 Billion CAD | -2.12% |
| 2013 Q2 | 987.71 Million CAD | -5.53% |
| 2012 Q1 | 1.06 Billion CAD | 12.75% |
| 2012 Q3 | 1.07 Billion CAD | 8.8% |
| 2012 Q4 | 1.03 Billion CAD | -3.7% |
| 2012 FY | 1.03 Billion CAD | 10.3% |
| 2012 Q2 | 991.51 Million CAD | -6.62% |
| 2011 Q3 | 867.06 Million CAD | 25.98% |
| 2011 Q4 | 941.74 Million CAD | 8.61% |
| 2011 FY | 941.74 Million CAD | 44.19% |
| 2011 Q1 | 615.16 Million CAD | -5.81% |
| 2011 Q2 | 688.23 Million CAD | 11.88% |
| 2010 Q4 | 653.12 Million CAD | -42.18% |
| 2010 Q3 | 1.12 Billion CAD | -2.46% |
| 2010 Q1 | 1.19 Billion CAD | -0.78% |
| 2010 Q2 | 1.15 Billion CAD | -3.19% |
| 2010 FY | 653.12 Million CAD | -45.82% |
| 2009 Q3 | 1.21 Billion CAD | -4.35% |
| 2009 Q1 | 1.32 Billion CAD | 2.62% |
| 2009 Q2 | 1.27 Billion CAD | -3.92% |
| 2009 Q4 | 1.2 Billion CAD | -0.95% |
| 2009 FY | 1.2 Billion CAD | -6.59% |
| 2008 Q4 | 1.29 Billion CAD | 8.9% |
| 2008 Q1 | 1.02 Billion CAD | 3.09% |
| 2008 Q2 | 1.15 Billion CAD | 12.64% |
| 2008 Q3 | 1.18 Billion CAD | 2.95% |
| 2008 FY | 1.29 Billion CAD | 30.19% |
| 2007 FY | 991.33 Million CAD | 18.33% |
| 2007 Q4 | 991.33 Million CAD | 4.14% |
| 2007 Q3 | 951.93 Million CAD | -3.43% |
| 2007 Q2 | 985.75 Million CAD | 2.96% |
| 2007 Q1 | 957.43 Million CAD | 14.29% |
| 2006 Q2 | 767.69 Million CAD | -4.09% |
| 2006 Q3 | 823.54 Million CAD | 7.28% |
| 2006 FY | 837.75 Million CAD | 8.06% |
| 2006 Q1 | 800.44 Million CAD | 3.25% |
| 2006 Q4 | 837.75 Million CAD | 1.73% |
| 2005 Q3 | 790.28 Million CAD | -7.95% |
| 2005 FY | 775.24 Million CAD | 26.33% |
| 2005 Q1 | 850.27 Million CAD | 38.56% |
| 2005 Q2 | 858.57 Million CAD | 0.98% |
| 2005 Q4 | 775.24 Million CAD | -1.9% |
| 2004 FY | 613.65 Million CAD | -18.19% |
| 2004 Q4 | 613.65 Million CAD | -2.98% |
| 2004 Q3 | 632.47 Million CAD | -5.68% |
| 2004 Q2 | 670.54 Million CAD | -8.24% |
| 2004 Q1 | 730.73 Million CAD | -2.58% |
| 2003 Q4 | 750.09 Million CAD | -3.01% |
| 2003 FY | 750.09 Million CAD | -11.41% |
| 2003 Q1 | 811.04 Million CAD | 0.0% |
| 2003 Q2 | 776.28 Million CAD | -4.29% |
| 2003 Q3 | 773.4 Million CAD | -0.37% |
| 2002 FY | 846.73 Million CAD | 7.41% |
| 2001 FY | 788.35 Million CAD | -1.75% |
| 2000 FY | 802.42 Million CAD | -10.04% |
| 1999 FY | 891.95 Million CAD | -11.18% |
| 1998 FY | 1 Billion CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | 1.82 Million USD | -17126.517% |
| Arem Pacific Corporation | 151.51 Thousand USD | -207563.369% |
| Assisted 4 Living, Inc. | - USD | -Infinity% |
| BioCorRx Inc. | 3.89 Million USD | -7977.532% |
| Bionik Laboratories Corp. | 2.39 Million USD | -13063.395% |
| Banyan Corp. | 2.43 Million USD | -12840.25% |
| Clearday, Inc. | 25.8 Million USD | -1119.111% |
| Dental Patient Care America, Inc. | - USD | -Infinity% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | 1.93 Million USD | -16195.36% |
| First Choice Healthcare Solutions, Inc. | 1.28 Million USD | -24411.617% |
| Selectis Health, Inc. | 25.17 Million USD | -1149.728% |
| Ethema Health Corporation | 20.52 Thousand USD | -1533218.713% |
| HealthLynked Corp. | 450 Thousand USD | -69819.333% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | - USD | -Infinity% |
| JRSIS Health Care Corporation | 24.95 Thousand USD | -1260970.14% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 54.46 Million USD | -477.645% |
| MedSmart Group Inc. | 50 Thousand USD | -629174.0% |
| North America Frac Sand, Inc. | - USD | -Infinity% |
| Nova Leap Health Corp. | 914.05 Thousand USD | -34322.07% |
| Nexteligent Holdings, Inc. | - USD | -Infinity% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 6.89 Million USD | -4463.493% |
| Raffles Medical Group Ltd | 52.43 Million USD | -500.037% |
| Ryman Healthcare Limited | 1.52 Billion USD | 79.332% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 57.07 Thousand USD | -551130.75% |
| Mycotopia Therapies, Inc. | - USD | -Infinity% |
| U.S. NeuroSurgical Holdings, Inc. | 58 Thousand USD | -542377.586% |
| Veltex Corporation | - USD | -Infinity% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | - USD | -Infinity% |